Cargando…
Efficacy of dose-reduced lenalidomide in patients with refractory or recurrent multiple myeloma
Purpose: Introduction of lenalidomide has expanded the therapeutic options for refractory and recurrent multiple myeloma (MM) patients. However, the application of the approved doses may be difficult in some patients due to adverse effects. Experimental design: Therefore, we evaluated the efficacy a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
German Medical Science GMS Publishing House
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183805/ https://www.ncbi.nlm.nih.gov/pubmed/21966287 http://dx.doi.org/10.3205/000149 |